
|Articles|December 27, 2021
FDA approves HIV pre-exposure preventive injection
Author(s)Keith A. Reynolds
Apretude is approved for use in at-risk adults and adolescents to reduce the risk of sexually acquired HIV.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
HIV screening, PrEP counseling get stronger ACOG recommendation
2
Telehealth expands maternal-fetal medicine access, with Jeffrey Chapa, MD
3
Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition
4
Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG
5




